Microvascular decompression for hemifacial spasm in patients >65 years of age

An analysis of outcomes and complications

Raymond F. Sekula, Andrew M. Frederickson, Gregory Arnone, Matthew R. Quigley, Mark Hallett

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Introduction: Few data are available to quantify the risks and benefits of microvascular decompression (MVD) in elderly patients with hemifacial spasm. Methods: Twenty-seven patients >65 years of age and 104 younger patients who underwent MVD for hemifacial spasm (HFS) over a 3-year period were analyzed retrospectively and compared. Results: Twenty-six (96.3%) elderly patients and 93 of 104 (89.4%) young patients reported a spasm-free status at a mean follow-up of 26.5 months after MVD. No significant difference in spasm-free status was noted. Cranial nerve complications and other major complications were compared, with no significant differences observed. Conclusions: Although this study does not offer definitive inclusion or exclusion criteria or clearly establish the safety of MVD for HFS in the elderly, our experience suggests that many elderly patients with HFS can undergo MVD safely, with outcomes and risk profiles similar to those of younger patients.

Original languageEnglish (US)
Pages (from-to)770-776
Number of pages7
JournalMuscle and Nerve
Volume48
Issue number5
DOIs
StatePublished - Nov 1 2013

Fingerprint

Microvascular Decompression Surgery
Hemifacial Spasm
Spasm
Cranial Nerves
Safety

All Science Journal Classification (ASJC) codes

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Sekula, Raymond F. ; Frederickson, Andrew M. ; Arnone, Gregory ; Quigley, Matthew R. ; Hallett, Mark. / Microvascular decompression for hemifacial spasm in patients >65 years of age : An analysis of outcomes and complications. In: Muscle and Nerve. 2013 ; Vol. 48, No. 5. pp. 770-776.
@article{11462cf5ebd84d6c902023e53a6209d0,
title = "Microvascular decompression for hemifacial spasm in patients >65 years of age: An analysis of outcomes and complications",
abstract = "Introduction: Few data are available to quantify the risks and benefits of microvascular decompression (MVD) in elderly patients with hemifacial spasm. Methods: Twenty-seven patients >65 years of age and 104 younger patients who underwent MVD for hemifacial spasm (HFS) over a 3-year period were analyzed retrospectively and compared. Results: Twenty-six (96.3{\%}) elderly patients and 93 of 104 (89.4{\%}) young patients reported a spasm-free status at a mean follow-up of 26.5 months after MVD. No significant difference in spasm-free status was noted. Cranial nerve complications and other major complications were compared, with no significant differences observed. Conclusions: Although this study does not offer definitive inclusion or exclusion criteria or clearly establish the safety of MVD for HFS in the elderly, our experience suggests that many elderly patients with HFS can undergo MVD safely, with outcomes and risk profiles similar to those of younger patients.",
author = "Sekula, {Raymond F.} and Frederickson, {Andrew M.} and Gregory Arnone and Quigley, {Matthew R.} and Mark Hallett",
year = "2013",
month = "11",
day = "1",
doi = "10.1002/mus.23800",
language = "English (US)",
volume = "48",
pages = "770--776",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

Microvascular decompression for hemifacial spasm in patients >65 years of age : An analysis of outcomes and complications. / Sekula, Raymond F.; Frederickson, Andrew M.; Arnone, Gregory; Quigley, Matthew R.; Hallett, Mark.

In: Muscle and Nerve, Vol. 48, No. 5, 01.11.2013, p. 770-776.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microvascular decompression for hemifacial spasm in patients >65 years of age

T2 - An analysis of outcomes and complications

AU - Sekula, Raymond F.

AU - Frederickson, Andrew M.

AU - Arnone, Gregory

AU - Quigley, Matthew R.

AU - Hallett, Mark

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Introduction: Few data are available to quantify the risks and benefits of microvascular decompression (MVD) in elderly patients with hemifacial spasm. Methods: Twenty-seven patients >65 years of age and 104 younger patients who underwent MVD for hemifacial spasm (HFS) over a 3-year period were analyzed retrospectively and compared. Results: Twenty-six (96.3%) elderly patients and 93 of 104 (89.4%) young patients reported a spasm-free status at a mean follow-up of 26.5 months after MVD. No significant difference in spasm-free status was noted. Cranial nerve complications and other major complications were compared, with no significant differences observed. Conclusions: Although this study does not offer definitive inclusion or exclusion criteria or clearly establish the safety of MVD for HFS in the elderly, our experience suggests that many elderly patients with HFS can undergo MVD safely, with outcomes and risk profiles similar to those of younger patients.

AB - Introduction: Few data are available to quantify the risks and benefits of microvascular decompression (MVD) in elderly patients with hemifacial spasm. Methods: Twenty-seven patients >65 years of age and 104 younger patients who underwent MVD for hemifacial spasm (HFS) over a 3-year period were analyzed retrospectively and compared. Results: Twenty-six (96.3%) elderly patients and 93 of 104 (89.4%) young patients reported a spasm-free status at a mean follow-up of 26.5 months after MVD. No significant difference in spasm-free status was noted. Cranial nerve complications and other major complications were compared, with no significant differences observed. Conclusions: Although this study does not offer definitive inclusion or exclusion criteria or clearly establish the safety of MVD for HFS in the elderly, our experience suggests that many elderly patients with HFS can undergo MVD safely, with outcomes and risk profiles similar to those of younger patients.

UR - http://www.scopus.com/inward/record.url?scp=84886750229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886750229&partnerID=8YFLogxK

U2 - 10.1002/mus.23800

DO - 10.1002/mus.23800

M3 - Article

VL - 48

SP - 770

EP - 776

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 5

ER -